ACACIA RES-TECH (ACTG) Upgraded by Zacks to NEUTRAL

Zacks Zacks Investment Research upgraded shares of ACACIA RES-TECH (ACTG) from UNDERPERFORM to NEUTRAL on December 10, 2012, with a target price of $25.50.

Acacia Research develops, licenses and provides products for the life science and media technology sectors. Acacia licenses its V-chip technology to television manufacturers and owns pioneering technology for digital streaming and video-on-demand. Acacia's CombiMatrix subsidiary is developing a bio-chip technology for the life science market.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on ACACIA RES-TECH (ACTG),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .

Be the first to comment

Leave a Reply